SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Gland Pharma informs about investors meeting

26 Dec 2022 Evaluate

Pursuant to Regulation 30 read with Part A of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015, Gland Pharma has informed that the Analyst/ Institutional Investor Meeting with SBI Mutual Fund held on 26th December 2022 in the form of in-person, One on One meeting. The schedule of the above-mentioned meeting is subject to change and the change may occur due to exigencies on the part of the Investor/ Analyst/ Company.

The above information is a part of company’s filings submitted to BSE.

Gland Pharma Share Price

1752.25 30.55 (1.77%)
15-Apr-2026 14:28 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1690.00
Dr. Reddys Lab 1216.90
Cipla 1224.55
Zydus Lifesciences 932.75
Lupin 2339.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×